ロード中...
Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites
INTRODUCTION: Metoprolol succinate is a long-acting beta-blocker prescribed for the management of hypertension (HTN) and other cardiovascular diseases. Metabolomics, the study of end-stage metabolites of upstream biologic processes, yield insight into mechanisms of drug effectiveness and safety. Our...
保存先:
| 出版年: | Hum Genomics |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7066769/ https://ncbi.nlm.nih.gov/pubmed/32160915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40246-020-00260-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|